Meet the group
Our leadership team has the clinical expertise and business acumen necessary to identify, innovate, and commercialize a diversified portfolio of high-margin products in attractive markets. We have experience in developing direct-to-consumer (DTC), medical, and professional markets to drive the adoption of our medical technologies toward the standard of care.
Institutions
The development of BlaDimiR is the result of a close collaboration between experts from various disciplines, combining knowledge in molecular biology, oncology, bioinformatics, biomedical engineering, and clinical analysis. This multidisciplinary approach has been key to the project's success, enabling the creation of an innovative and effective diagnostic system for the detection of bladder cancer.
Build your dreams
